Date:2/26/2013

the use of forward-looking terminology such as "believes," expects" or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk that the amendment is not executed or not executed on terms described above, the Company's ability to remain in compliance with the covenants under its credit facility, the Company's ability to file its Quarterly Report on Form 10-Q no later than the 5^th day following its prescribed due date, and other risks discussed in the company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume a duty to update these forward-looking statements.Company Contact:Investor Relations Contact:Mr. Richard F. Fitzgerald

Hayden IRChief Financial Officer

Brett Maas TechPrecision Corporation

Phone: 646-536-7331 Tel: 1-484-693-1702

Email: brett@haydenir.comEmail: Fitzgeraldr@techprecision.comwww.techprecision.com
'/>"/>

SOURCE TechPrecision Corporation Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. TechPrecision Receives Additional Medical Purchase Orders Exceeding $1.5 Million
2. United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results
3. Precision Optics Corporation, Inc. Operating Results for Six Months Ended December 31, 2012 and Recent Operating Activities
4. Psychemedics Corporation Announces Record Revenues For 2012; Declares 66th Consecutive Quarterly Dividend
5. MGC Diagnostics Corporation to Report First Quarter Fiscal 2013 Financial Results on Tuesday, March 5, 2013
6. ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders
7. Imalux Corporation Engages Advisor to Explore Strategic Options
8. DURECT Corporation Invites You to Join its Fourth Quarter 2012 Earnings Conference Call
9. Volcano Corporation Provides Additional Guidance For 2013
10. Tomorrows Outlook in Todays Market - Research Report on Toyota Motor Corporation, Honda Motor Co., Ltd., Yahoo! Inc., AOL, Inc. and Aegerion Pharmaceuticals, Inc.
11. Medical Equipment Suppliers in Good Health - Research Report on Bruker Corporation, Agilent Technologies Inc., General Electric Company, Becton, Dickinson and Co. and Thermo Fisher Scientific Inc.